bromopyruvate has been researched along with Cardiac Toxicity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bai, J; Bai, N; Chi, J; Ding, X; Liu, J; Nie, C; Yang, W; Zhan, C; Zheng, M | 1 |
Bai, N; Li, G; Li, J; Li, L; Li, T; Li, W; Liu, G; Yang, J; Yang, W; Zhan, C; Zhao, H; Zheng, M | 1 |
2 other study(ies) available for bromopyruvate and Cardiac Toxicity
Article | Year |
---|---|
Combined Usage of Trimetazidine With 3-Bromopyruvate May Lead to Cardiotoxicity by Activating Oxidative Stress and Apoptosis in Rats.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Cardiotoxicity; Cardiovascular Agents; Energy Metabolism; Enzyme Inhibitors; Heart Diseases; Male; Myocytes, Cardiac; Oxidative Stress; Pyruvates; Rats, Wistar; Signal Transduction; Trimetazidine; Ventricular Function, Left | 2021 |
Rotenone and 3-bromopyruvate toxicity impacts electrical and structural cardiac remodeling in rats.
Topics: Action Potentials; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cardiotoxicity; Connexin 43; Heart Rate; Heart Ventricles; Insecticides; Male; Potassium Channels, Inwardly Rectifying; Pyruvates; Rats, Wistar; Refractory Period, Electrophysiological; Risk Assessment; Rotenone; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Remodeling | 2020 |